Vanda stock wins FDA orphan drug tag for nerve disorder drug
Habababa Vanda Pharmaceuticals (Nasdaq: VNDA) gained after three straight sessions of declines on Friday after it announced that the U.S. Food and Drug Administration had granted orphan drug designation for its experimental treatment…
